Literature DB >> 26749388

The freezing method of cleavage stage embryos has no impact on the weight of the newborns.

N Kaartinen1, K Kananen2, H Huhtala3, S Keränen4, H Tinkanen5.   

Abstract

PURPOSE: The aim of this study was to study the effect of the embryo freezing method on the birth weight of newborns from frozen embryo transfer (FET) cycles, and the pregnancy results of cleavage stage embryos cryopreserved by slow freezing or vitrification.
METHODS: This is a retrospective cohort study undertaken in a University Hospital IVF unit using concurrently both the slow-freezing and the vitrification techniques. All frozen-thawed and vitrified-warmed day 2 and day 3 embryo transfers during the time period from 1 April 2009 to 31 November 2013 were included in the study.
RESULTS: There was no statistically significant weight difference between newborns from vitrified or slow-frozen embryos (3588 vs 3670 g). A higher post-thaw viability rate was achieved after cryopreservation by the vitrification technique compared to the slow-freezing protocol (83.4 vs 61.4%). The miscarriage rate was lower in the vitrification group (15.7 vs 29.0%). The live birth rates were similar (19.5 vs 19.1%) in the slow-freezing and vitrification groups, respectively. Among vitrified embryos, 7.4 embryos needed to be thawed to produce one delivery; in the slow-freezing group, that number was 11.9.
CONCLUSIONS: The freezing method has no impact on the weight of the newborn. With lower post-thaw survival rates and higher miscarriage rates, the slow-freezing cryopreservation protocol is inferior to the vitrification technique.

Entities:  

Keywords:  Cryopreservation; Frozen embryo transfer; Slow freezing; Vitrification

Mesh:

Year:  2016        PMID: 26749388      PMCID: PMC4785169          DOI: 10.1007/s10815-015-0642-8

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  34 in total

1.  Human cleavage-stage embryo vitrification is comparable to slow-rate cryopreservation in cycles of assisted reproduction.

Authors:  Martin Graham Wilding; Clemente Capobianco; Nadia Montanaro; Genc Kabili; Loredana Di Matteo; Enrico Fusco; Brian Dale
Journal:  J Assist Reprod Genet       Date:  2010-07-17       Impact factor: 3.412

Review 2.  A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos.

Authors:  David H Edgar; Debra A Gook
Journal:  Hum Reprod Update       Date:  2012-04-25       Impact factor: 15.610

3.  Cryopreservation of day 2-3 embryos by vitrification yields better outcome than slow freezing.

Authors:  Jacob Levron; Oshrit Leibovitz; Masha Brengauz; Hila Gitman; Gil M Yerushalmi; Eldad Katorza; Itai Gat; Shai E Elizur
Journal:  Gynecol Endocrinol       Date:  2014-01-07       Impact factor: 2.260

4.  Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders.

Authors:  Bruce S Shapiro; Said T Daneshmand; Forest C Garner; Martha Aguirre; Cynthia Hudson; Shyni Thomas
Journal:  Fertil Steril       Date:  2011-07-06       Impact factor: 7.329

5.  Clinical outcomes following cryopreservation of blastocysts by vitrification or slow freezing: a population-based cohort study.

Authors:  Z Li; Y A Wang; W Ledger; D H Edgar; E A Sullivan
Journal:  Hum Reprod       Date:  2014-10-14       Impact factor: 6.918

6.  Large baby syndrome in singletons born after frozen embryo transfer (FET): is it due to maternal factors or the cryotechnique?

Authors:  A Pinborg; A A Henningsen; A Loft; S S Malchau; J Forman; A Nyboe Andersen
Journal:  Hum Reprod       Date:  2014-01-09       Impact factor: 6.918

7.  Can repeated IVF-ICSI-cycles be avoided by using blastocysts developing from poor-quality cleavage stage embryos?

Authors:  Noora Kaartinen; Pia Das; Kirsi Kananen; Heini Huhtala; Helena Tinkanen
Journal:  Reprod Biomed Online       Date:  2014-12-11       Impact factor: 3.828

Review 8.  Cryopreservation of human embryos by vitrification or slow freezing: a systematic review and meta-analysis.

Authors:  Kalliopi E Loutradi; Efstratios M Kolibianakis; Christos A Venetis; Evangelos G Papanikolaou; George Pados; Ioannis Bontis; Basil C Tarlatzis
Journal:  Fertil Steril       Date:  2007-11-05       Impact factor: 7.329

9.  Neonatal outcome after vitrified day 3 embryo transfers: a preliminary study.

Authors:  Gottumukkala Achyuta Rama Raju; Gomedhikam Jaya Prakash; Kota Murali Krishna; Kalagara Madan
Journal:  Fertil Steril       Date:  2008-08-09       Impact factor: 7.329

10.  A randomized controlled trial comparing two vitrification methods versus slow-freezing for cryopreservation of human cleavage stage embryos.

Authors:  Giovanna Fasano; Nicolas Fontenelle; Anne-Sophie Vannin; Jamila Biramane; Fabienne Devreker; Yvon Englert; Anne Delbaere
Journal:  J Assist Reprod Genet       Date:  2013-12-08       Impact factor: 3.412

View more
  3 in total

1.  Effect of frozen/thawed embryo transfer on birthweight, macrosomia, and low birthweight rates in US singleton infants.

Authors:  Julia F Litzky; Sheree L Boulet; Navid Esfandiari; Yujia Zhang; Dmitry M Kissin; Regan N Theiler; Carmen J Marsit
Journal:  Am J Obstet Gynecol       Date:  2017-12-29       Impact factor: 8.661

Review 2.  Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review.

Authors:  Stefano Palomba; Roy Homburg; Susanna Santagni; Giovanni Battista La Sala; Raoul Orvieto
Journal:  Reprod Biol Endocrinol       Date:  2016-11-04       Impact factor: 5.211

Review 3.  Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance.

Authors:  Laura Rienzi; Clarisa Gracia; Roberta Maggiulli; Andrew R LaBarbera; Daniel J Kaser; Filippo M Ubaldi; Sheryl Vanderpoel; Catherine Racowsky
Journal:  Hum Reprod Update       Date:  2017-03-01       Impact factor: 15.610

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.